CompletedPhase 3NCT04636671

Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Trieste
Principal Investigator
Marco Confalonieri, MD
University of Trieste
Intervention
Methylprednisolone(drug)
Enrollment
690 target
Eligibility
18 years · All sexes
Timeline
20212022

Study locations (1)

Collaborators

Centro di Riferimento Oncologico - Aviano · National Institute for the Infectious Diseases (L. Spallanzani) - Rome

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04636671 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials